Function and regulation of human copper-transporting ATPases

被引:640
作者
Lutsenko, Svetlana [1 ]
Barnes, Natalie L.
Bartee, Mee Y.
Dmitriev, Oleg Y.
机构
[1] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA
[2] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada
关键词
D O I
10.1152/physrev.00004.2006
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Copper-transporting ATPases (Cu-ATPases) ATP7A and ATP7B are evolutionarily conserved polytopic membrane proteins with essential roles in human physiology. The Cu-ATPases are expressed in most tissues, and their transport activity is crucial for central nervous system development, liver function, connective tissue formation, and many other physiological processes. The loss of ATP7A or ATP7B function is associated with severe metabolic disorders, Menkes disease, and Wilson disease. In cells, the Cu-ATPases maintain intracellular copper concentration by transporting copper from the cytosol across cellular membranes. They also contribute to protein biosynthesis by delivering copper into the lumen of the secretory pathway where metal ion is incorporated into copper-dependent enzymes. The biosynthetic and homeostatic functions of Cu-ATPases are performed in different cell compartments; targeting to these compartments and the functional activity of Cu-ATPase are both regulated by copper. In recent years, significant progress has been made in understanding the structure, function, and regulation of these essential transporters. These studies raised many new questions related to specific physiological roles of Cu-ATPases in various tissues and complex mechanisms that control the Cu-ATPase function. This review summarizes current data on the structural organization and functional properties of ATP7A and ATP7B as well as their localization and functions various tissues, and discusses the current models of regulated trafficking of human Cu-ATPases.
引用
收藏
页码:1011 / 1046
页数:36
相关论文
共 316 条
[21]   Menkes' disease with a Dandy-Walker variant:: case report [J].
Bekiesiñska-Figatowska, M ;
Rokicki, D ;
Walecki, J ;
Gremida, M .
NEURORADIOLOGY, 2001, 43 (11) :948-950
[22]   Copper depletion down-regulates expression of the Alzheimer's disease amyloid-β precursor protein gene [J].
Bellingham, SA ;
Lahiri, DK ;
Maloney, B ;
La Fontaine, S ;
Multhaup, G ;
Camakaris, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :20378-20386
[23]   Whole animal copper flux assessed by positron emission tomography in the Long-Evans cinnamon rat - a feasibility study [J].
Bissig, KD ;
Honer, M ;
Zimmermann, K ;
Summer, KH ;
Solioz, M .
BIOMETALS, 2005, 18 (01) :83-88
[24]   Expression of the human menkes ATPase in Xenopus laevis oocytes [J].
Bissig, KD ;
La Fontaine, S ;
Mercer, JFB ;
Solioz, M .
BIOLOGICAL CHEMISTRY, 2001, 382 (04) :711-714
[25]  
Borjigin J, 1999, J NEUROSCI, V19, P1018
[26]   Tyrosinase folding and copper loading in vivo:: A crucial role for calnexin and α-glucosidase II [J].
Branza-Nichita, N ;
Petrescu, AJ ;
Dwek, RA ;
Wormald, MR ;
Platt, FM ;
Petrescu, SM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (03) :720-725
[27]   Diagnosis of Wilson's disease: an experience over three decades [J].
Brewer, GJ .
GUT, 2002, 50 (01) :136-136
[28]   Treatment of Wilson disease with ammonium tetrathiomolybdate .2. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy [J].
Brewer, GJ ;
Johnson, V ;
Dick, RD ;
Kluin, KJ ;
Fink, JK ;
Brunberg, JA .
ARCHIVES OF NEUROLOGY, 1996, 53 (10) :1017-1025
[29]   Diagnosis and treatment of Wilson's disease [J].
Brewer, GJ ;
Fink, JK ;
Hedera, P .
SEMINARS IN NEUROLOGY, 1999, 19 (03) :261-270
[30]   Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation [J].
Buiakova, OI ;
Xu, J ;
Lutsenko, S ;
Zeitlin, S ;
Das, K ;
Das, S ;
Ross, BM ;
Mekios, C ;
Scheinberg, IH ;
Gilliam, TC .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1665-1671